Brett Ewald

Brett Ewald is the Chief Operating Officer at Radionetics Oncology. Prior to this role, Brett served as the Senior Vice President of Development and Corporate Strategy at DNAtrix and the Head of Clinical Operations Planning at Novartis Oncology. With a background in pharmacology and biology, Brett has extensive experience in the oncology field, focusing on early clinical development and strategy. Through his various roles, Brett has demonstrated strong leadership, strategic planning, and successful development of clinical trials and partnerships within the pharmaceutical industry.